English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Computer-driven formulation development of Ginsenoside Rh2 ternary solid dispersion Journal article
Lu, Tianshu, Wu, Tongchuan, Zhong, Hao, Li, Xue, Zhang, Yunsen, Yue, Hao, Dai, Yulin, Li, Haifeng, Ouyang, Defang. Computer-driven formulation development of Ginsenoside Rh2 ternary solid dispersion[J]. Drug Delivery and Translational Research, 2024.
Authors:  Lu, Tianshu;  Wu, Tongchuan;  Zhong, Hao;  Li, Xue;  Zhang, Yunsen; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.7/5.5 | Submit date：2024/07/04
(20s)-ginsenoside Rh2  Dissolution Rate  Gelucire 44/14  Molecular Dynamics Simulation  Ternary Solid Dispersion  
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 Journal article
Huang, Mu Yang, Chen, Yu Chi, Lyu, Wen Yu, He, Xin Yu, Ye, Zi Han, Huang, Can Yu, He, Xin Ling, Chen, Xiuping, Chen, Xiaobing, Zhang, Baoxian, Kai, Guoyin, Zhang, Xiaolei, Li, Ting, Huang, Mingqing, Lu, Jin Jian. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10[J]. Pharmacological Research, 2023, 198, 106988.
Authors:  Huang, Mu Yang;  Chen, Yu Chi;  Lyu, Wen Yu;  He, Xin Yu;  Ye, Zi Han; et al.
Favorite | TC[WOS]:11 TC[Scopus]:14  IF:9.1/9.0 | Submit date：2024/01/02
Combination Treatment  Ginsenoside Rh2  Pd-1/pd-l1  t Cells  Tumor Microenvironment  
c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2 Journal article
Su, Min Xia, Xu, Yu Lian, Jiang, Xiao Ming, Huang, Mu Yang, Zhang, Le Le, Yuan, Luo Wei, Xu, Xiao Huang, Zhu, Qi, Gao, Jian Li, Lu, Jia Hong, Chen, Xiuping, Huang, Ming Qing, Wang, Yitao, Lu, Jin Jian. c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2[J]. Acta Pharmaceutica Sinica B, 2022, 12(3), 1240-1253.
Authors:  Su, Min Xia;  Xu, Yu Lian;  Jiang, Xiao Ming;  Huang, Mu Yang;  Zhang, Le Le; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:14.7/14.1 | Submit date：2022/04/06
Aggresomes  C-myc  Everolimus  Ginsenoside Rh2  Lung Cancer  P62  Paraptosis  Trib3  
Anticancer Effects of Ginsenoside Rh2: A Systematic Review Journal article
He, Xin Ling, Xu, Xiao Huang, Shi, Jia Jie, Huang, Mingqing, Wang, Yitao, Chen, Xiuping, Lu, Jin Jian. Anticancer Effects of Ginsenoside Rh2: A Systematic Review[J]. Current Molecular Pharmacology, 2022, 15(1), 179-189.
Authors:  He, Xin Ling;  Xu, Xiao Huang;  Shi, Jia Jie;  Huang, Mingqing;  Wang, Yitao; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:2.4/2.8 | Submit date：2022/02/21
Cancer  Cytotoxicity  Ginseng  Ginsenoside Rh2  Mechanism  Natural Compound  
Liposome-based delivery systems for ginsenoside Rh2: in vitro and in vivo comparisons Journal article
Linqiang Xu, Hua Yu, Shaoping Yin, Ruixia Zhang, Yudan Zhou, Juan Li. Liposome-based delivery systems for ginsenoside Rh2: in vitro and in vivo comparisons[J]. Journal of Nanoparticle Research, 2015, 17(10).
Authors:  Linqiang Xu;  Hua Yu;  Shaoping Yin;  Ruixia Zhang;  Yudan Zhou; et al.
Favorite | TC[WOS]:25 TC[Scopus]:22  IF:2.1/2.2 | Submit date：2019/01/24
Ginsenoside Rh2  Liposomes  Mpegpla  Biodistribution  Anti-cancer  Drug Delivery  Nanomedicine  Health Effects